AccessBio signs ₩22B COVID-19 antigen test kit supply contract with Intrivo Diagnostics

AccessBio signed a contract with Intrivo Diagnostics to supply COVID-19 antigen test kits for the US market. The contract value is ₩22 billion.

“엑세스바이오는 의료기기 유통업체 Intrivo Diagnostics와 COVID-19 항원진단키트 공급계약을 체결했다고 8일 공시했다.”fnnews.com

• 1 source
• fnnews.com엑세스바이오, 코로나 항원진단키트 220억 계약 - 파이낸셜뉴스Oct 8, 2021

Summarized from public sources; check the original articles before acting on it.